Top 3 Canadian AI Healthcare Stocks To Watch In November 2026

AI is suddenly under political fire, with US lawmakers floating curbs on new data centers just as heavy AI spending helped push corporate earnings growth to levels not seen since the 1980s. That tension puts long term infrastructure projects in question and shifts attention to areas where AI can show clear, real world value. One of the most compelling is Canadian healthcare, so this article walks through three AI driven healthcare stocks from our screener worth a closer look.

The three stocks below are only a first sample from this theme, and the full screen surfaced 2 more AI driven healthcare companies with narratives that look just as compelling but are not covered in this article. If you want to identify potential leaders early in this shift, head straight into the Transformative Artificial intelligence (AI) Healthcare Stocks screener to filter and analyze the highest conviction plays in one place.

Telescope Innovations (CNSX:TELI)

Overview: Telescope Innovations develops AI-ready chemical reactor hardware, DIRECTINJECT-LC lab analytics, and contract research that support pharmaceutical and chemical R&D workflows.

Operations: Telescope Innovations generates about CA$7.3 million from chemicals, largely tied to United States customers at roughly CA$5.3 million in sales.

Market Cap: CA$26 million

Telescope Innovations operates at the AI healthcare tools edge, building DIRECTINJECT-LC and automation-ready reactors that can feed clean, real-time reaction data into drug discovery algorithms. The business is currently loss making and trades at a higher P/S ratio than some peers, so funding and execution discipline are important. A change in how quickly this niche automation line converts into more dependable contracts could influence expectations regarding growth and valuation pressure.

That kind of inflection point is exactly where a deeper breakdown helps, so tap into the DCF valuation analysis for Telescope Innovations to see how the current pricing compares with its cash potential.

Profound Medical (TSX:PRN)

Overview: Profound Medical develops AI powered, MRI guided systems like TULSA PRO and Sonalleve that deliver incision free, image guided tissue ablation therapies.

Operations: Profound Medical generates about $19 million from medical technology, with roughly $12 million from the US and $6 million from Canada.

Market Cap: CA$362 million

Profound Medical integrates AI into prostate cancer therapy, using MRI images, robotic ultrasound and closed loop temperature control to steer treatment in real time. The company is currently loss making and relies on physician adoption of TULSA PRO and Sonalleve. As a result, execution around hospital partnerships and reimbursement could significantly influence margins and demand.

That adoption curve is exactly what matters here, so walk through the 1 key reward and 1 important warning sign and see how Profound Medical’s opportunity compares with its execution risk.

Perimeter Medical Imaging AI (TSXV:PINK)

Overview: Perimeter Medical Imaging AI develops OCT imaging systems and the AI driven Claire OCT with ImgAssist, which provide real time breast surgery margin visualization.

Operations: Perimeter Medical Imaging AI generates about $2.1 million in medical imaging systems revenue, entirely from Canadian customers.

Market Cap: CA$27.6 million

Perimeter Medical Imaging AI integrates AI into the operating room through Claire OCT with ImgAssist, giving surgeons real time margin insight during breast conserving surgery rather than relying only on pathology after the fact. Revenue is still small and funding needs are meaningful.

With that funding gap in mind, scan the Perimeter Medical Imaging AI financial health report to see whether Perimeter Medical Imaging AI’s balance sheet can support an accelerating commercialization push.

Seeking Alternatives Before The Crowd

Fresh breakout stories rarely stay quiet for long. Momentum gets spotted, prices move, and the easy entry points vanish. Scan these under the radar ideas now and get in early.

• Spot strong cash generators early and sift through the 6 high quality undervalued stocks before the crowd chases the same quality at far richer multiples.
• Ride structural tailwinds in automation by checking the curated 90 robotics and automation stocks while these operators are still flying below most investors’ screens.
• Stay ahead of the next power bottleneck and comb through the 40 power grid technology and infrastructure stocks while the grid transformation story is only just gaining traction.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com